Literature DB >> 7529148

IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils.

L A Bober1, T A Waters, C C Pugliese-Sivo, L M Sullivan, S K Narula, M J Grace.   

Abstract

IL-4 is a T-helper cell derived cytokine that has effects on myelomonocytic cell maturation and activation. We have studied the effect of IL-4 on neutrophilic maturation using the cell line HL-60 and found that it has a profound effect on the maturation and activation of the cell line. The treatment of HL-60 cells with recombinant hu IL-4 (0.15 to 15.0 ng/ml) induced a shift in the percentage of HL-60 cells staining positive for chloroacetate esterase enzyme activity (indicating commitment to the neutrophilic lineage). IL-4 increased surface expression of the neutrophil-lineage antigen WEM G11, the complement receptors CR3 (CD11b) and CR1 (CD35), but not for the monocyte differentiation antigen CD14. IL-4 treated HL-60 cells demonstrated enhanced Fc- and complement-mediated phagocytic capacity and increased hexose-monophosphate shunt activity. In addition, IL-4 was capable of sustaining the neutrophil maturation of HL-60 cells that had been pre-treated for 24 h with DMSO. To investigate the effect of IL-4 on the mature neutrophil, we studied freshly isolated and rested human peripheral blood neutrophils. In the absence of other stimuli, neutrophils were induced by IL-4 to have significantly elevated phagocytic responses. The response was specific since treatment with anti-human IL-4 abolished phagocytic stimulation. Finally, IL-4 treatment also stimulated resting neutrophils to migrate toward zymosan-activated serum (ZAS) and human IL-5. The results demonstrate that IL-4 is a potent maturation factor for myelocytes to become neutrophils and that IL-4 can stimulate resting mature neutrophils.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529148      PMCID: PMC1534134          DOI: 10.1111/j.1365-2249.1995.tb03483.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

Review 1.  Lung inflammation, its significance for asthma therapy.

Authors:  J Morley; D Smith
Journal:  Agents Actions       Date:  1989-01

Review 2.  The neutrophil, a professional killer of bacteria, may be controlled by T cells.

Authors:  P A Campbell
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Murine B-cell stimulatory factor-1 (BSF-1)/interleukin-4 (IL-4) is a multilineage colony-stimulating factor that acts directly on primitive hemopoietic progenitors.

Authors:  K Kishi; J N Ihle; D L Urdal; M Ogawa
Journal:  J Cell Physiol       Date:  1989-06       Impact factor: 6.384

4.  Activation of human B lymphocytes through CD40 and interleukin 4.

Authors:  A Vallé; C E Zuber; T Defrance; O Djossou; M De Rie; J Banchereau
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

5.  Multiple effects of human recombinant interleukin 4 on human myeloid monocyte cell lines.

Authors:  T Noma; H Nakakubo; K Hama; T Honjo
Journal:  Immunol Lett       Date:  1989-06-15       Impact factor: 3.685

6.  Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture.

Authors:  Y Sonoda; T Okuda; S Yokota; T Maekawa; Y Shizumi; H Nishigaki; S Misawa; H Fujii; T Abe
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

7.  Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5.

Authors:  B H van Leeuwen; M E Martinson; G C Webb; I G Young
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

8.  Interleukin-4 is a neutrophil activator.

Authors:  H Boey; R Rosenbaum; J Castracane; L Borish
Journal:  J Allergy Clin Immunol       Date:  1989-05       Impact factor: 10.793

9.  Interferon-gamma overcomes the glucocorticoid-mediated and the interleukin-4-mediated inhibition of interleukin-1 beta synthesis in human monocytes.

Authors:  T Geiger; J Arnold; C Rordorf; R Henn; K Vosbeck
Journal:  Lymphokine Cytokine Res       Date:  1993-10

10.  Changes in insulin receptor expression in HL60 cells induced to differentiate towards neutrophils or monocytes.

Authors:  J M Lord; C M Bunce; R J Duncan; I D Phillips; K I Shennan; K Docherty; G Brown
Journal:  J Mol Endocrinol       Date:  1988-11       Impact factor: 5.098

View more
  12 in total

1.  Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.

Authors:  D Girard; R Paquin; A D Beaulieu
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  ISSLS PRIZE IN BASIC SCIENCE 2017: Intervertebral disc/bone marrow cross-talk with Modic changes.

Authors:  Stefan Dudli; David C Sing; Serena S Hu; Sigurd H Berven; Shane Burch; Vedat Deviren; Ivan Cheng; Bobby K B Tay; Todd F Alamin; Ma Agnes Martinez Ith; Eric M Pietras; Jeffrey C Lotz
Journal:  Eur Spine J       Date:  2017-01-31       Impact factor: 3.134

Review 4.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 6.  Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.

Authors:  Xiaomin Deng; James P Luyendyk; Patricia E Ganey; Robert A Roth
Journal:  Pharmacol Rev       Date:  2009-09       Impact factor: 25.468

7.  Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern.

Authors:  Celina Arruda; Rita C Valente-Ferreira; Adriana Pina; Suely S Kashino; Raquel A Fazioli; Celidéia A C Vaz; Marcello F Franco; Alexandre C Keller; Vera L G Calich
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

8.  Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans.

Authors:  A Mencacci; G Del Sero; E Cenci; C F d'Ostiani; A Bacci; C Montagnoli; M Kopf; L Romani
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

9.  Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils.

Authors:  Patrice E Poubelle; Arpita Chakravarti; Maria J Fernandes; Karine Doiron; Andrée-Anne Marceau
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line.

Authors:  K A Rockett; R Brookes; I Udalova; V Vidal; A V Hill; D Kwiatkowski
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.